← Back to Search

Negative Pressure Wound Therapy

NPWT treated wounds for Pressure Sore (NPWTR Trial)

N/A
Waitlist Available
Led By Caroline Fife, MD
Research Sponsored by U.S. Wound Registry
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Provision of NPWT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up events occurring between initial treatment and cessation of npwt treatment. event outcome information will be as recorded or status at 30 days following onset
Awards & highlights
No Placebo-Only Group

Summary

The goal of the Negative Pressure Wound Therapy Registry (NPWTR) for Wounds is to provide real world patient data from electronic health records submitted to meet Stage 2 Meaningful Use in order to understand the effectiveness and safety of various NPWT devices and methods among patients with chronic wounds and ulcers. Randomized, controlled trials to establish product efficacy routinely exclude patients with the co-morbid conditions common to patients seen in usual clinical practice and thus the results of these Randomized Controlled Trials (RCTs) tend to be non-generalizable. Little is known about the effectiveness of NPWT among typical patients. Patient registries are also ideal for assessing long term safety issues in these devices.

Eligible Conditions
  • Pressure Sore
  • Wound Dehiscence
  • Ulcer
  • Foot Ulcer
  • Burns
  • Venous Ulcers
  • Surgical Wound Separation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~events occurring between initial treatment and cessation of npwt treatment. event outcome information will be as recorded or status at 30 days following onset
This trial's timeline: 3 weeks for screening, Varies for treatment, and events occurring between initial treatment and cessation of npwt treatment. event outcome information will be as recorded or status at 30 days following onset for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Healing
Secondary study objectives
Duration of NPWT
Side effects and adverse Events During Therapy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: NPWT treated woundsExperimental Treatment1 Intervention
NPWT from any FDA cleared NPWT device including
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NPWT
2014
N/A
~90

Find a Location

Who is running the clinical trial?

U.S. Wound RegistryLead Sponsor
5 Previous Clinical Trials
250,000 Total Patients Enrolled
Caroline Fife, MDPrincipal InvestigatorUS Wound Registry
~2410 spots leftby Oct 2025